The Middle East has been rocked in recent years by upheaval. While the potential for disruption is real, the region has been characterized as well by rapid growth in the healthcare sector. One of its brightest lights is Israel. It is a developed, industrialized nation that, despite ongoing conflict with neighboring Arab countries, remains committed to making substantial technological and medical advances through education and high R&D expenditures.

Over recent decades much of Israel’s economic growth and export performance has been reliant on research-intensive industries.  Its dense population and focus on innovation positions Israel well to drive a significant amount of growth for pharmaceutical and medical device manufacturers moving forward.